Skip to content
The Bio Report cover art

All episodes

The Bio Report, 641 episodes. Page 7 of 7.

#
Title
601

Examining the State of Sleep

602

TheStreet’s Adam Feuerstein Previews ASCO 2015

603

Home-Brew Morphine, Dual Use Technology, and the Biologist’s Repsonsibilities

604

Reinventing Tech Transfer

605

Thinking Narrowly About Antibiotics

606

Promise Shown in Different Approach to Alzheimer’s

607

Innovative Drugs Drive Big Increase in U.S. Spending

608

Ensuring Digital Health Technologies Benefit Older People

609

How the Sugar Industry Influenced Research to Protect Its Interests

610

Examining The White House’s Plan to Combat Drug-Resistant Bacteria

611

Weighing Adverse Events to Get at a Drug’s Real Costs

612

How One Company Is Reinventing Drug Development

613

Why Patent Trolling Threatens Biopharma

614

Shifting Venture Investment Raises Concerns

615

Will Policy Triumph Over Politics in 21st Century Cures Act

616

Democratizing the World of Healthcare Analytics

617

Will Funding for Obama’s Precision Medicine Initiative Match Its Ambition

618

Should Investors Temper Their Enthusiasm for CAR-T Therapies

619

What to Do About the United States’ Declining Investment in R&D

620

Why Big Pharma Hasn’t Been Able to Fix Its Revenue Gap with M&A

621

Remembering Industry Pioneer Ron Cape

622

Moving from Chronic Therapies to Cures

623

What’s in Store for the Biotech Industry in 2015

624

A Look at the Year That Was in Biotech

625

Why Privacy Concerns May Limit Big Data’s Payoff

626

Calculating the Cost of Drug Development and What it Means

627

How New Funding Models Are Accelerating Drug Development

628

Telemedicine Grows, but Reimbursement Remains an Obstacle

629

The Power of IBM’s Watson Is Coming to an App Near You

630

Brittany Maynard and the Debate over the Right to Die

631

What’s Driving the Booming Market for Orphan Drugs

632

Why Interoperability Is Much More than a Technology Problem

633

The Lean Startup Takes Hold in the Life Sciences

634

Enlisting Monoclonal Antibodies to Combat Bacterial Resistance

635

The Forces Bringing Disruptive Change to Healthcare

636

How One Foundation is Getting the Biggest Bang for Its R&D Bucks

637

International Collaboration Seeks to Drive Breakthroughs in Progressive MS

638

Will Increased FDA Regulation of Diagnostics Speed or Slow Development of Personalized Medicine

639

Using Human Biology to Improve R&D

640

Reengineering Drug Discovery and Development

641

The Year in Biotech So Far and What’s Ahead

642

Epirus Sees Opportunities for Biosimilars Outside U.S.